By Kevin Madagan

Carlyle (NASDAQ: CG) and SK Capital Partners will acquire bluebird bio (NASDAQ: BLUE), according to a news release.

bluebird, founded in 2010 and based in Somerville, Massachusetts, is a gene therapy maker.

Carlyle, with

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and SK Capital to Acquire bluebird bio

By Kevin Madagan

Latticework Capital Management (LCM) and Edgehill Management have completed a strategic investment in Life Science Connect (LSC), according to a news release.

LSC, founded in 2014 and based in Pittsburgh, Pennsylvania, is a life science digital

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Latticework and Edgehill Invest in Life Science Connect

By Kevin Madagan

Waud Capital Partners has announced the acquisition of Mopec Group from Blackford Capital.

Mopec, founded in 1992 and based in Madison Heights, Michigan, is a supplier and manufacturer of anatomic and forensic pathology equipment, technology, consumable

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Waud Acquires Mopec From Blackford

Whistler Capital Partners has invested in GXP-Storage, according to a news release.

GXP, based in Middlesex, North Carolina, is provider of regulated material management solutions for regulated life sciences research, manufacturing and healthcare.

Whistler Capital, founded in

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Whistler Capital Invests in GXP-Storage

By Kevin Madagan

Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.

The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Acquires Nektar Therapeutics’ PEGylation

Ampersand Capital Partners and GHO Capital Partners will acquire Avid Bioservices for approximately $1.1 billion, according to a news release.

Avid (NASDAQ: CDMO), formed in 2002 and based in Orange County, California, is a biologics contract development and manufacturing

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand and GHO Acquire Avid Bioservices for $1.1 Billion

By Kevin Madagan

Waud Capital Partners (WCP) has announced the acquisition of Science Exchange.

Science Exchange, founded in 2011 and based in San Francisco, is a provider of life sciences procurement and supplier management software-as-a-service (SaaS) solutions.

WCP

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Waud Acquires Science Exchange

Genstar Capital has announced a strategic majority investment in Flourish Research, according to a news release.

Flourish, founded in 2001 and based in Apex, North Carolina, is a multi-site clinical trial organization focused on areas including cardiovascular, metabolic

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Genstar Invests in Flourish Research

GI Partners has made a majority investment in eClinical Solutions, according to a news release.

eClinical, founded in 2012 and based in Mansfield, Massachusetts, is a global provider of digital clinical software and services.

GI Partners, based

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: GI Partners Acquires eClinical Solutions